on NFL BIOSCIENCES (EPA:ALNFL)
NFL Biosciences Releases 2025 Financial Agenda
On March 5th, 2025, NFL Biosciences, a biopharmaceutical company based in Montpellier, France, announced its financial schedule for 2025. The company is known for developing botanical drugs aimed at treating addictions. Key financial events in the agenda include the release of the 2024 annual results on April 11th, 2025, and the Annual General Meeting scheduled for June 25th, 2025, in Montpellier. Additionally, the 2025 half-year results will be announced on October 24th, 2025. All press releases will be issued following the closure of the stock market.
These dates are provided for informational purposes and could be subject to changes. NFL Biosciences, listed on Euronext Growth Paris, continues its mission to deliver natural and safer therapeutic solutions for addiction treatment.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NFL BIOSCIENCES news